Table 1.
Patient No | Diagnosis | Gender | Onset age | Heredity | Protein change (dbSNP) | APOE | Function | Pathogenic | Population frequencya | SIFT scoreb | PolyPhen-2 scoreb |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | AD | F | 50 | Yes | PSEN1 P264L (rs63750301) | ε3/ε4 | Missense | Yes | 0.0000040 | 0 | 1 |
2 | AD | M | 42 | Yes | PSEN1 P264L (rs63750301) | ε3/ε4 | Missense | Yes | 0.0000040 | 0 | 1 |
3 | AD | M | 34 | No | PSEN1 M146V (rs63750306) | ε3/ε3 | Missense | Yes | - | 0.01 | 0.985 |
4 | AD | M | 65 | Yes | PSEN2 I144L (rs764718172) | ε3/ε3 | Missense | Unknown | 0.0000080 | 0.01 | 0.257 |
5 | bvFTD | M | 69 | Yes | PSEN2 A252T (rs138836272) | ε3/ε3 | Missense | Unknown | 0.00023 | 0.42 | 0.172 |
FUS Δ229-231 (rs767564995) | Deletion | Unknown | 0.00021 | - | - | ||||||
6 | AD | M | 59 | Yes | FUS Ser57Δ (rs777545405) | ε4/ε4 | Deletion | Unknown | 0.00017 | - | - |
7 | svPPA | M | 64 | Yes | FUS Δ166-167 (rs537605135) | ε4/ε4 | Deletion | Unknown | 0.00030 | - | - |
8 | AD | F | 57 | Yes | GRN A324V (rs758636128) | ε3/ε3 | Missense | Unknown | 0.000024 | 0.21 | 0.129 |
9 | AD | M | 59 | Yes | MAPT V224G (rs141120474) | ε4/ε4 | Missense | Unknown | 0.0021 | 0 | 0.187 |
10 | MCI | M | 61 | Yes | MAPT A239T (rs63750096) | ε3/ε4 | Missense | Unknown | 0.00063 | 0.27 | 0.079 |
11 | AD | M | 56 | Yes | APOE R269G (rs267606661) | ε3/ε4 | Missense | Unknown | 0.00036 | 0 | 0.533 |
12 | AD | M | 44 | Yes | APP Δ690-695 | ε3/ε3 | Deletion | Yes | - | - | - |
13 | AD | M | 40 | Yes | APP Δ690-695 | ε3/ε3 | Deletion | Yes | - | - | - |
aPopulation frequency was obtained from gnomAD database, except for rs767564995 for which dbSNP was used
bPolyPhen-2 and SIFT scores were obtained using Ensembl Variant Effect Predictor. These scores are used to predict whether amino acid substitution is likely to affect protein function. The SIFT score ranges from 0.0 (deleterious) to 1.0 (tolerated). The PolyPhen-2 score ranges from 0.0 (tolerated) to 1.0 (deleterious)